4//SEC Filing
Wang Julia Aijun 4
Accession 0001651308-24-000056
CIK 0001651308other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:54 PM ET
Size
7.6 KB
Accession
0001651308-24-000056
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Wang Julia Aijun
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2024-06-05+256,659→ 256,659 totalExercise: $12.23Exp: 2034-06-04→ Ordinary Shares (256,659 underlying) - Award
Ordinary Shares
2024-06-05+136,240→ 456,326 total
Footnotes (3)
- [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Documents
Issuer
BeiGene, Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001860279
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:54 PM ET
- Size
- 7.6 KB